Will Adams

Will Adams is the current CEO, President, and Co-Founder at Riparian Pharmaceuticals. Will has extensive experience in the field of biomolecular detection and cardiovascular disease. Will has worked as a Scientific Consultant for Firefly Bioworks and as a Research Fellow for Brigham & Women's Hospital | Harvard Medical School. Will has been published in various scientific journals and has presented their research at international scientific meetings. Will is also the co-inventor of two patents related to tools for cardiovascular drug discovery.

Will Adams earned a PhD in Biomedical Engineering from Harvard University. Prior to that, they earned a MS in Applied Mathematics from Harvard University. Will also has a BS in Biomedical Engineering from Harvard University.

Some direct reports include Rafael Gil - Principal Scientist, Ron Wester - Head Of Chemistry.